From March 1980 to December 1997, 545 patients underwent 560 mitral valve repairs at the Heart Institute of HCFMUSP. Ages ranged from 3 months to 86 years with mean age of 42.2 and standard deviation of 21.4 years. Two hundred and seventy four (50.3%) were male. Ethiology was rheumatic disease in 234 (42.9%) patients. The techniques used were: quadrangular resection of posterior leaflet in 204 (36.5%) patients, annuloplasty with posterior sling in 139 (24.5%), Carpentier ring annuloplasty in 102 (18.2%), segmentary posterior annuloplasty in 37 (6.6%) and others. Associated procedures were performed in 267 (35.6%) patients with the most frequent tricuspid valve repair in 95 (17%) patients. Immediate mortality was 3.7% (21 patients). The linearizated rates of reoperation, thromboembolism, endocarditis and hemolysis, were respectively 2.9%, 0.6%, 0.3% and 0.1% patient/ year. The actuarial survival rate at 17 years was 76.8 ± 10.8% and the actuarial freedom from endocarditis, thromboembolism, reoperation and hemolisis at 17 years was 98.9 ± 0.6%, 93.9 ± 3.7%, 61.0 ± 7.9% and 99.7 ± 0.2%, respectively. We conclude that patients submitted to mitral valve repair presented satisfactory evolution.
Mitral valve; Heart valve disease
